Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane F Apperley

Blood

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Blood|November 26, 2013
How I treat leukemia during pregnancyDragana Milojkovic, Jane F Apperley
Blood|October 23, 2010
Three decades of transplantation for chronic myeloid leukemia: what have we learned?Jirí Pavlu, Richard M Szydlo, John M Goldman, et al.
Blood|December 13, 2006
Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioningCharles Crawley, Simona Iacobelli, Bo Björkstrand, et al.
Blood|April 26, 2003
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of responseEdward D Seaton, Richard M Szydlo, Edward Kanfer, et al.
Blood|March 16, 2007
The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemiaMohamad Mohty, Agnes S M Yong, Richard M Szydlo, et al.
Blood|September 8, 2005
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CMLAgnes S M Yong, Richard M Szydlo, John M Goldman, et al.
Blood|May 3, 2002
Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantationEduardo Olavarria, Charles Craddock, Francesco Dazzi, et al.
Blood|May 14, 2010
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinibManuel Sobrinho-Simões, Vicki Wilczek, Joannah Score, et al.
Blood|June 21, 2008
Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemiaMohamad Mohty, Richard M Szydlo, Agnes S M Yong, et al.
Blood|March 7, 2008
The effects of imatinib on pregnancy outcomeSeonaid M Pye, Jorge Cortes, Patricia Ault, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Blood|November 26, 2013
How I treat leukemia during pregnancyDragana Milojkovic, Jane F Apperley
Blood|October 23, 2010
Three decades of transplantation for chronic myeloid leukemia: what have we learned?Jirí Pavlu, Richard M Szydlo, John M Goldman, et al.
Blood|December 13, 2006
Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioningCharles Crawley, Simona Iacobelli, Bo Björkstrand, et al.
Blood|April 26, 2003
Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of responseEdward D Seaton, Richard M Szydlo, Edward Kanfer, et al.
Blood|March 16, 2007
The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemiaMohamad Mohty, Agnes S M Yong, Richard M Szydlo, et al.
Blood|September 8, 2005
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CMLAgnes S M Yong, Richard M Szydlo, John M Goldman, et al.
Blood|May 3, 2002
Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantationEduardo Olavarria, Charles Craddock, Francesco Dazzi, et al.
Blood|May 14, 2010
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinibManuel Sobrinho-Simões, Vicki Wilczek, Joannah Score, et al.
Blood|June 21, 2008
Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemiaMohamad Mohty, Richard M Szydlo, Agnes S M Yong, et al.
Blood|March 7, 2008
The effects of imatinib on pregnancy outcomeSeonaid M Pye, Jorge Cortes, Patricia Ault, et al.
Pageof 4